Holders — by stockHoldings — by fund
SILVERARC CAPITAL MANAGEMENT, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001816307
$962.2M
disclosed book value
73
positions
5.7%
largest position share
Positions, as of 2026-06-30
top 73 of 73 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | 206,234 | $55.0M | 5.7% |
| 2 | CELCCELCUITY INC | 500,996 | $52.4M | 5.4% |
| 3 | COGTCOGENT BIOSCIENCES INC | 1.3M | $49.6M | 5.2% |
| 4 | UROGEN PHARMA LTD | 1.3M | $47.9M | 5% |
| 5 | IMNMIMMUNOME INC | 2.0M | $42.7M | 4.4% |
| 6 | DNTHDIANTHUS THERAPEUTICS INC | 390,000 | $38.0M | 4% |
| 7 | RYTMRHYTHM PHARMACEUTICALS INC | 311,461 | $34.6M | 3.6% |
| 8 | ORKAORUKA THERAPEUTICS INC | 352,802 | $33.6M | 3.5% |
| 9 | GLUEMONTE ROSA THERAPEUTICS INC | 1.1M | $26.8M | 2.8% |
| 10 | SNDXSYNDAX PHARMACEUTICALS INC | 1.2M | $26.5M | 2.8% |
| 11 | ELVNENLIVEN THERAPEUTICS INC | 489,382 | $24.8M | 2.6% |
| 12 | IMVTIMMUNOVANT INC | 619,096 | $23.9M | 2.5% |
| 13 | ERASERASCA INC | 1.3M | $23.1M | 2.4% |
| 14 | SGMTSAGIMET BIOSCIENCES INC | 2.9M | $22.6M | 2.4% |
| 15 | ABVXABIVAX SA | 169,593 | $22.6M | 2.3% |
| 16 | PRAXPRAXIS PRECISION MEDICINES I | 65,679 | $22.0M | 2.3% |
| 17 | KODKODIAK SCIENCES INC | 546,256 | $21.3M | 2.2% |
| 18 | ARK ETF TRPUT | 500,000 | $21.0M | 2.2% |
| 19 | DFTXDEFINIUM THERAPEUTICS INC | 400,000 | $18.8M | 2% |
| 20 | VCYTVERACYTE INC | 318,001 | $18.7M | 1.9% |
| 21 | SYNDAX PHARMACEUTICALS INCCALL | 693,600 | $15.2M | 1.6% |
| 22 | GHGUARDANT HEALTH INC | 99,826 | $15.0M | 1.6% |
| 23 | CCCCC4 THERAPEUTICS INC | 3.0M | $14.2M | 1.5% |
| 24 | ZBIOZENAS BIOPHARMA INC | 509,789 | $12.9M | 1.3% |
| 25 | TRVITREVI THERAPEUTICS INC | 678,095 | $12.6M | 1.3% |
| 26 | HELIX ACQUISITION CORP III | 1.2M | $12.5M | 1.3% |
| 27 | ALXOALX ONCOLOGY HLDGS INC | 5.7M | $11.9M | 1.2% |
| 28 | MANEVERADERMICS INC | 95,000 | $11.7M | 1.2% |
| 29 | XENEXENON PHARMACEUTICALS INC | 186,821 | $11.3M | 1.2% |
| 30 | AVLNAVALYN PHARMACEUTICALS INC | 330,487 | $10.9M | 1.1% |
| 31 | BIIBBIOGEN INC | 48,101 | $10.4M | 1.1% |
| 32 | ACRSACLARIS THERAPEUTICS INC | 1.9M | $10.3M | 1.1% |
| 33 | CERSCERUS CORP | 3.5M | $10.1M | 1.1% |
| 34 | AVTXAVALO THERAPEUTICS INC | 500,402 | $9.2M | 1% |
| 35 | BNTCBENITEC BIOPHARMA INC | 679,826 | $9.1M | 0.9% |
| 36 | PCVXVAXCYTE INC | 145,000 | $8.4M | 0.9% |
| 37 | WGSGENEDX HOLDINGS CORP | 122,269 | $8.4M | 0.9% |
| 38 | SVRASAVARA INC | 1.4M | $8.3M | 0.9% |
| 39 | OVIDOVID THERAPEUTICS INC | 3.1M | $8.3M | 0.9% |
| 40 | ORICORIC PHARMACEUTICALS INC | 738,873 | $8.0M | 0.8% |
| 41 | ORIC PHARMACEUTICALS INCCALL | 682,600 | $7.4M | 0.8% |
| 42 | MONTE ROSA THERAPEUTICS INCCALL | 300,000 | $7.3M | 0.8% |
| 43 | CMPSCOMPASS PATHWAYS PLC | 503,382 | $7.1M | 0.7% |
| 44 | COMPUGEN LTD | 3.2M | $6.8M | 0.7% |
| 45 | SLDBSOLID BIOSCIENCES INC | 668,450 | $6.7M | 0.7% |
| 46 | ABIVAX SACALL | 50,000 | $6.7M | 0.7% |
| 47 | IBIOIBIO INC | 3.5M | $6.2M | 0.6% |
| 48 | IRONDISC MEDICINE INC | 82,800 | $6.1M | 0.6% |
| 49 | ALKERMES PLC | 113,494 | $5.9M | 0.6% |
| 50 | SYRESPYRE THERAPEUTICS INC | 59,959 | $5.3M | 0.6% |
| 51 | ARTVARTIVA BIOTHERAPEUTICS INC | 525,000 | $5.1M | 0.5% |
| 52 | CTNMCONTINEUM THERAPEUTICS INC | 296,135 | $4.9M | 0.5% |
| 53 | UNIQURE NV | 105,000 | $4.8M | 0.5% |
| 54 | RESEARCH ALLIANCE CORP III | 360,000 | $3.9M | 0.4% |
| 55 | ABEOABEONA THERAPEUTICS INC | 610,407 | $3.8M | 0.4% |
| 56 | INSMINSMED INC | 34,438 | $3.7M | 0.4% |
| 57 | KPTIKARYOPHARM THERAPEUTICS INC | 297,460 | $2.9M | 0.3% |
| 58 | KYMERA THERAPEUTICS INCPUT | 25,000 | $2.9M | 0.3% |
| 59 | CAMPCAMP4 THERAPEUTICS CORP | 653,594 | $2.9M | 0.3% |
| 60 | ELUTELUTIA INC | 2.2M | $2.1M | 0.2% |
| 61 | RVMDREVOLUTION MEDICINES INC | 10,000 | $1.9M | 0.2% |
| 62 | SIONSIONNA THERAPEUTICS INC | 42,478 | $1.9M | 0.2% |
| 63 | ABSCI CORPORATIONPUT | 157,600 | $1.8M | 0.2% |
| 64 | TELATELA BIO INC | 2.1M | $1.6M | 0.2% |
| 65 | ACHVACHIEVE LIFE SCIENCE INC | 227,178 | $1.5M | 0.2% |
| 66 | FULCRUM THERAPEUTICS INCCALL | 391,900 | $1.4M | 0.1% |
| 67 | GUTSFRACTYL HEALTH INC | 1.6M | $1.3M | 0.1% |
| 68 | CONNECT BIOPHARMA HLDGS LTD | 545,000 | $1.3M | 0.1% |
| 69 | CRESCENT BIOPHARMA INC. | 59,104 | $1.1M | 0.1% |
| 70 | CLRBCELLECTAR BIOSCIENCES INC | 321,728 | $894,404 | 0.1% |
| 71 | FHTXFOGHORN THERAPEUTICS INC | 45,975 | $224,358 | 0% |
| 72 | ADGMADAGIO MED HLDGS INC | 224,360 | $146,193 | 0% |
| 73 | RCKTWROCKET PHARMACEUTICALS INC | 104,828 | $356 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.